Trial intelligence / Profile preview

Superiority study of insulin glargine over sitagliptin in insulin-naïve type 2 diabetes patients on metformin

2008-000516-32Phase 4Completed

Sponsor
Sanofi
Start
Jun 2008
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Insulin glargine arm with Sitagliptin arm (2 arms). Primary endpoint: Change in HbA1c from baseline to study endpoint. Started Jun 2008; status: completed.

02

Drugs

insulin glarginesitagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2008-000516-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-000516-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call